Piggyback IOL effective in highly myopic eyes

Article

Piggyback multifocal IOLs used for a hyperopic-presbyopic surprise after cataract surgery are successful in highly myopic eyes, claims a study in the Journal of the British Contact Lens Association.

Piggyback multifocal IOLs used for a hyperopic-presbyopic surprise after cataract surgery are successful in highly myopic eyes, claims a study in the Journal of the British Contact Lens Association.

A team managed by Dr Valentin Huerva, Ophthalmology Department, Universitary Hospital Arnau de Vilanova, Lleida, Spain, completed a case report on a 43-year-old woman with high myopia who also presented with dense subcapsular cataracts.

The refractive result was to achieve a spherical equivalent refractive error of +2.25. The team used a refractive multifocal +3 D Sulcoflex 653F to overcome refractive surprise, with an additional 3.5 D for near vision. This achieved a best-corrected visual acuity of 20/40 and good intermediate vision for computer work.

The IOL enables good near-intermediate visual acuity and spectacle independence in highly myopic eyes with good near visual acuity. It could be possible to correct residual refractive errors by implanting the IOL following earlier implantation of a monofocal IOL.

To read the abstract please click here.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.